Evaluation of Indoleamine 2,3-Dioxygenase (IDO) Expression in Osteosarcoma: Insights From a 10-Year Retrospective Cohort
Asim V. Farooq(University of Chicago), Kashif Asghar(Shaukat Khanum Memorial Cancer Hospital and Research Center)
Cited by 1
Related Papers
PD-L1 is Fascinating but IDO Needs Attention in Non-HCV and Non-HBV-Associated Hepatocellular Carcinoma Patients
|Journal of Hepatocellular Carcinoma|2023|2
Expression of PD-L1 clones (22C3 and 28-8) in hepatocellular carcinoma: a tertiary cancer care hospital experience
|Egyptian Liver Journal|2024|1